Responsible Growth Priorities And The Hybridised Trial Of The Future

Responsible Growth Priorities And The Hybridised Trial Of The Future

Dr Ian Smith (Co-founder, Director and Chief Medical Officer) and Chris Dodd (Chief Commercial Officer) recently spoke to Jo Shorthouse at In Vivo to discuss the practicalities and reality of running clinical trial sites as a business, the efficiencies found with the SMO model, the challenge of patient recruitment as well as the decentralized and hybridized trial model.

To listen to the podcast click here